SATECH Revenue and Competitors

Chehalis, WA USA

Location

N/A

Total Funding

Materials

Industry

Estimated Revenue & Valuation

  • SATECH's estimated annual revenue is currently $5.2M per year.(i)
  • SATECH's estimated revenue per employee is $224,700

Employee Data

  • SATECH has 23 Employees.(i)
  • SATECH grew their employee count by -12% last year.

SATECH's People

NameTitleEmail/Phone
1
VP Sales and Business DevelopmentReveal Email/Phone
2
VP Sales and MarketingReveal Email/Phone
3
Sales ManagerReveal Email/Phone
4
Sales ExecutiveReveal Email/Phone
5
Marketing SpealistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.2M363%N/AN/A
#2
$28.6M893%N/AN/A
#3
$30.5M95-1%N/AN/A
#4
$7.7M3030%N/AN/A
#5
$11.6M45-24%N/AN/A
#6
$8.7M343%N/AN/A
#7
$66.4M1886%N/AN/A
#8
$9M356%N/AN/A
#9
$21.7M759%N/AN/A
#10
$619.7M13795%N/AN/A
Add Company

What Is SATECH?

Seamless Attenuating Technologies (SATECH) is a Washington-based manufacturer specializing in the development and marketing of SmartCells®, a new generation of cushioning technology. The SmartCells® technology has broad application in many markets where improving safety and reducing fatigue, stress, impact shock, and vibration are critical factors. Applications include the industrial work place for relieving fatigue and improving productivity in standing workers, and the senior care market for reducing fall injuries. SATECH’s innovative ways continue to apply extensive, on-going research and development toward new applications which include the creation of mat-less anti-fatigue, force-attenuating flooring solutions which are particularly well adapted to pharmacies, labs and airline, fall protection and high-performance environments. The new SmartCells® technology employs a remarkable dual-stiffness flooring solution that does not impair balance, while providing a stable surface for normal activities that ‘softens’ under impact to provide fall-impact protection. The SmartCells® cushioned flooring technology is the subject of a variety of clinical studies to further quantify its many benefits and to reduce risk and liability.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$5.2M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8M370%N/A
#2
$14.4M552%N/A
#3
$11.3M570%N/A
#4
$16.5M578%N/A
#5
$34.3M1047%N/A